|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sylvester RJ, van der Meijden AP,
Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW and
Kurth K: Predicting recurrence and progression in individual
patients with stage Ta T1 bladder cancer using EORTC risk tables: a
combined analysis of 2596 patients from seven EORTC trials. Eur
Urol. 49:465–466; discussion 475–477. 2006. View Article : Google Scholar
|
|
3
|
Nisticò P, Bissell MJ and Radisky DC:
Epithelial-mesenchymal transition: General principles and
pathological relevance with special emphasis on the role of matrix
metalloproteinases. Cold Spring Harb Perspect Biol. 4:42012.
View Article : Google Scholar
|
|
4
|
Chang CJ, Chao CH, Xia W, Yang JY, Xiong
Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, et al: p53 regulates
epithelial-mesenchymal transition and stem cell properties through
modulating miRNAs. Nat Cell Biol. 13:317–323. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xie D, Gore C, Liu J, Pong RC, Mason R,
Hao G, Long M, Kabbani W, Yu L, Zhang H, et al: Role of DAB2IP in
modulating epithelial-to-mesenchymal transition and prostate cancer
metastasis. Proc Natl Acad Sci USA. 107:2485–2490. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gjerdrum C, Tiron C, Høiby T, Stefansson
I, Haugen H, Sandal T, Collett K, Li S, McCormack E, Gjertsen BT,
et al: Axl is an essential epithelial-to-mesenchymal
transition-induced regulator of breast cancer metastasis and
patient survival. Proc Natl Acad Sci USA. 107:1124–1129. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang H, Li YY, Wu YY and Nie YQ:
Expression and clinical significance of hedgehog signaling pathway
related components in colorectal cancer. Asian Pac J Cancer Prev.
13:2319–2324. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Flemban A and Qualtrough D: The potential
role of hedgehog signaling in the luminal/basal phenotype of breast
epithelia and in breast cancer invasion and metastasis. Cancers
(Basel). 7:1863–1884. 2015. View Article : Google Scholar
|
|
9
|
Lin H, Jackson GA, Lu Y, Drenkhahn SK,
Brownstein KJ, Starkey NJ, Lamberson WR, Fritsche KL, Mossine VV,
Besch-Williford CL, et al: Inhibition of Gli/hedgehog signaling in
prostate cancer cells by “cancer bush” Sutherlandia frutescens
extract. Cell Biol Int. 40:131–142. 2016. View Article : Google Scholar
|
|
10
|
Huang L, Walter V, Hayes DN and Onaitis M:
Hedgehog-GLI signaling inhibition suppresses tumor growth in
squamous lung cancer. Clin Cancer Res. 20:1566–1575. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X, Deng W, Nail CD, Bailey SK, Kraus
MH, Ruppert JM and Lobo-Ruppert SM: Snail induction is an early
response to Gli1 that determines the efficiency of epithelial
transformation. Oncogene. 25:609–621. 2006.
|
|
12
|
Chen JS, Huang XH, Wang Q, Huang JQ, Zhang
LJ, Chen XL, Lei J and Cheng ZX: Sonic hedgehog signaling pathway
induces cell migration and invasion through focal adhesion
kinase/AKT signaling-mediated activation of matrix
metalloproteinase (MMP)-2 and MMP-9 in liver cancer.
Carcinogenesis. 34:10–19. 2013. View Article : Google Scholar
|
|
13
|
Chaudhary P and Vishwanatha JK: c-Jun
NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S
and Bcl2 sensitize prostate cancer cells to Fas- and
mitochondria-mediated apoptosis by tetrandrine. Biochem Pharmacol.
91:457–473. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu W, Kou B, Ma ZK, Tang XS, Lv C, Ye M,
Chen JQ, Li L, Wang XY and He DL: Tetrandrine suppresses
proliferation, induces apoptosis, and inhibits migration and
invasion in human prostate cancer cells. Asian J Androl.
17:850–853. 2015.PubMed/NCBI
|
|
15
|
Wu K, Zhou M, Wu QX, Yuan SX, Wang DX, Jin
JL, Huang J, Yang JQ, Sun WJ, Wan LH, et al: The role of IGFBP-5 in
mediating the anti-proliferation effect of tetrandrine in human
colon cancer cells. Int J Oncol. 46:1205–1213. 2015.
|
|
16
|
Wu JM, Chen Y, Chen JC, Lin TY and Tseng
SH: Tetrandrine induces apoptosis and growth suppression of colon
cancer cells in mice. Cancer Lett. 287:187–195. 2010. View Article : Google Scholar
|
|
17
|
Qin R, Shen H, Cao Y, Fang Y, Li H, Chen Q
and Xu W: Tetrandrine induces mitochondria-mediated apoptosis in
human gastric cancer BGC-823 cells. PLoS One. 8:e764862013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang TH, Wan JY, Gong X, Li HZ and Cheng
Y: Tetrandrine enhances cytotoxicity of cisplatin in human
drug-resistant esophageal squamous carcinoma cells by inhibition of
multi-drug resistance-associated protein 1. Oncol Rep.
28:1681–1686. 2012.PubMed/NCBI
|
|
19
|
Sun YF and Wink M: Tetrandrine and
fangchinoline, bisbenzylisoquinoline alkaloids from Stephania
tetrandra can reverse multidrug resistance by inhibiting
P-glycoprotein activity in multidrug resistant human cancer cells.
Phytomedicine. 21:1110–1119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao JL, Ji X, He TC, Zhang Q, He K, Zhao
Y, Chen SH and Lv GY: Tetrandrine suppresses cancer angiogenesis
and metastasis in 4T1 tumor bearing mice. Evid Based Complement
Alternat Med. 2013:2650612013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiao W, Jiang Y, Men Q, Yuan L, Huang Z,
Liu T, Li W and Liu X: Tetrandrine induces G1/S cell cycle arrest
through the ROS/Akt pathway in EOMA cells and inhibits angiogenesis
in vivo. Int J Oncol. 46:360–368. 2015.
|
|
22
|
He BC, Gao JL, Zhang BQ, Luo Q, Shi Q, Kim
SH, Huang E, Gao Y, Yang K, Wagner ER, et al: Tetrandrine inhibits
Wnt/β-catenin signaling and suppresses tumor growth of human
colorectal cancer. Mol Pharmacol. 79:211–219. 2011. View Article : Google Scholar :
|
|
23
|
Li X, Su B, Liu R, Wu D and He D:
Tetrandrine induces apoptosis and triggers caspase cascade in human
bladder cancer cells. J Surg Res. 166:e45–e51. 2011. View Article : Google Scholar
|
|
24
|
Iwatsuki M, Mimori K, Yokobori T, Ishi H,
Beppu T, Nakamori S, Baba H and Mori M: Epithelial-mesenchymal
transition in cancer development and its clinical significance.
Cancer Sci. 101:293–299. 2010. View Article : Google Scholar
|
|
25
|
Amakye D, Jagani Z and Dorsch M:
Unraveling the therapeutic potential of the Hedgehog pathway in
cancer. Nat Med. 19:1410–1422. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Briscoe J and Thérond PP: The mechanisms
of Hedgehog signalling and its roles in development and disease.
Nat Rev Mol Cell Biol. 14:416–429. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Harris LG, Pannell LK, Singh S, Samant RS
and Shevde LA: Increased vascularity and spontaneous metastasis of
breast cancer by hedgehog signaling mediated upregulation of cyr61.
Oncogene. 31:3370–3380. 2012. View Article : Google Scholar :
|
|
28
|
Zhang J, Zhang GX, Chen FF, He BS, Ye F
and Pan XL: Effect of Helicobacter pylori lipopolysaccharide on
expression of Gli and Ptch-1 proteins in sonic hedgehog signaling
pathway of gastric mucosa GES-1 cells. Zhejiang Da Xue Xue Bao Yi
Xue Ban. 42:543–549. 2013.In Chinese. PubMed/NCBI
|
|
29
|
Reichl P, Haider C, Grubinger M and
Mikulits W: TGF-β in epithelial to mesenchymal transition and
metastasis of liver carcinoma. Curr Pharm Des. 18:4135–4147. 2012.
View Article : Google Scholar
|
|
30
|
Mallini P, Lennard T, Kirby J and Meeson
A: Epithelial-to-mesenchymal transition: What is the impact on
breast cancer stem cells and drug resistance. Cancer Treat Rev.
40:341–348. 2014. View Article : Google Scholar
|
|
31
|
Satelli A and Li S: Vimentin in cancer and
its potential as a molecular target for cancer therapy. Cell Mol
Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Voulgari A and Pintzas A:
Epithelial-mesenchymal transition in cancer metastasis: Mechanisms,
markers and strategies to overcome drug resistance in the clinic.
Biochim Biophys Acta. 1796:75–90. 2009.PubMed/NCBI
|
|
33
|
Li X, Ma Q, Duan W, Liu H, Xu H and Wu E:
Paracrine sonic hedgehog signaling derived from tumor epithelial
cells: A key regulator in the pancreatic tumor microenvironment.
Crit Rev Eukaryot Gene Expr. 22:97–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jeng KS, Sheen IS, Jeng WJ, Yu MC, Hsiau
HI and Chang FY: High expression of Sonic Hedgehog signaling
pathway genes indicates a risk of recurrence of breast carcinoma.
Onco Targets Ther. 7:79–86. 2013. View Article : Google Scholar
|
|
35
|
ten Haaf A, Bektas N, von Serenyi S, Losen
I, Arweiler EC, Hartmann A, Knüchel R and Dahl E: Expression of the
glioma-associated oncogene homolog (GLI) 1 in human breast cancer
is associated with unfavourable overall survival. BMC Cancer.
9:2982009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Abidi A: Hedgehog signaling pathway: a
novel target for cancer therapy: vismodegib, a promising
therapeutic option in treatment of basal cell carcinomas. Indian J
Pharmacol. 46:3–12. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yoo YA, Kang MH, Lee HJ, Kim BH, Park JK,
Kim HK, Kim JS and Oh SC: Sonic hedgehog pathway promotes
metastasis and lymphangiogenesis via activation of Akt, EMT, and
MMP-9 pathway in gastric cancer. Cancer Res. 71:7061–7070. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lei J, Ma J, Ma Q, Li X, Liu H, Xu Q, Duan
W, Sun Q, Xu J, Wu Z, et al: Hedgehog signaling regulates hypoxia
induced epithelial to mesenchymal transition and invasion in
pancreatic cancer cells via a ligand-independent manner. Mol
Cancer. 12:662013. View Article : Google Scholar : PubMed/NCBI
|
